article thumbnail

Application of telemedicine technology for cardiovascular diseases management during the COVID-19 pandemic: a scoping review

Frontiers in Cardiovascular Medicine

BackgroundRecently, the use of telemedicine technology has increased due to the Covid-19 pandemic. This study aimed to identify the applications of telemedicine for cardiovascular diseases management during the Covid-19 pandemic.MethodsThis scoping study was conducted in 2023.

article thumbnail

COVID-19 myocarditis illusions

Dr. Anish Koka

I’m a cardiologist, and the first disconnect that became glaringly obvious very quickly was the impact COVID was having on the heart. As I walked through COVID rooms in the Spring of 2020 trying to hold my breath, I waited for a COVID cardiac tsunami. There never was a cardiac tsunami from COVID. But it got worse.

article thumbnail

COVID-19 vaccine and postural orthostatic tachycardia syndrome

HeartRhythm

We would like to comment on the publication “Postural orthostatic tachycardia syndrome after COVID-19 vaccination [1].” This study evaluated patients who received the mRNA COVID-19 vaccine and then developed new or worsening symptoms of Postural Orthostatic Tachycardia Syndrome (POTS).

article thumbnail

Hepatitis B Vaccine Birth Dose Uptake Unimpacted By COVID-19 Pandemic

HCPLive

Refusal of hospital-administered birth doses of the hepatitis B vaccine declined in Washington, DC, from 2017-2022 despite pandemic-related disruptions to other childhood vaccines.

article thumbnail

Prognostic value of ECG monitor findings in COVID-19

Open Heart

Aims COVID-19 can cause severe illness and multiorgan dysfunction. Acute myocardial damage has been detected in a significant portion of patients with COVID-19; therefore, several studies have reported that electrocardiographic findings could be used to evaluate the severalty of COVID-19.

article thumbnail

Study identifies hospitalized COVID-19 patients at elevated mortality risk

Medical Xpress - ECG

A simple electrocardiogram (ECG) can pinpoint hospitalized COVID-19 patients at high risk of death who might need intensive management. That's the finding of a study presented at EHRA 2022, a scientific congress of the European Society of Cardiology (ESC).

article thumbnail

Trends in sepsis-associated cardiovascular disease mortality in the United States, 1999 to 2022

Frontiers in Cardiovascular Medicine

This study aims to assess the trends of sepsis-associated CVD mortality rates and variations in mortality based on demographics and regions in the US.MethodsThe Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research (CDC WONDER) database was used to identify CVD and sepsis-related deaths from 1999 to 2022.